Stocks and Investing
Stocks and Investing
Fri, October 4, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Derek Archila Initiated (atyr) at Buy and Held Target at $17 on, Oct 4th, 2024
Derek Archila of Wells Fargo, Initiated "aTyr Pharma, Inc." (ATYR) at Buy and Held Target at $17 on, Oct 4th, 2024.
Derek has made no other calls on ATYR in the last 4 months.
There are 3 other peers that have a rating on ATYR. Out of the 3 peers that are also analyzing ATYR, 0 agree with Derek's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Derek
- Roger Song of "Jefferies" Initiated at Strong Buy and Held Target at $9 on, Thursday, September 5th, 2024
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Thursday, August 15th, 2024
- Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $16 on, Wednesday, August 14th, 2024
Contributing Sources